Biochemical and endocrine aspects of oxytocin production by the mammalian corpus luteum
Reproductive Biology and Endocrinology volume 1, Article number: 92 (2003)
A review of the current state of knowledge of oxytocin production by the preovulatory follicle and corpus luteum is presented. Corpora lutea of a number of mammalian species have been found to synthesize oxytocin. However, the synthesis and secretion of this nanopeptide by the corpus luteum of the ruminant has been most extensively studied because of the potential role of this peptide in facilitating luteal regression. While much information exists relative to various biochemical and endocrine factors that impact on oxytocin gene expression, this aspect about luteal synthesis of this peptide hormone remains enigmatic. Prostaglandin F-2α (PGF-2α) has been shown to be a primary endogenous hormone responsible for triggering luteal secretion of oxytocin. Details are provided regarding the PGF-2α-induced intracellular signal transduction pathway that ultimately results in exocytosis of luteal oxytocin. Evidence is also presented for potential autocrine/paracrine actions of oxytocin in regulating progesterone production by luteal and granulosa cells. Concluding remarks highlight aspects about luteal oxytocin production that require further research.
Ott and Scott  are believed to be the first investigators to unknowingly demonstrate that the corpus luteum is a rich source of oxytocin. These researchers reported that an aqueous extract of the corpus luteum when injected into a goat, stimulated immediate milk flow.
Forty-three years elapsed before Du Vigneaud et al.  reported the amino acid sequence of oxytocin and nearly another 30 years passed before Wathes and Swann  demonstrated by radioimmunoassay and chromatography that the ovine and human corpus luteum contained oxytocin. In subsequent years, presence of luteal oxytocin was reported for the cow , cynomolgus monkey , goat , baboon  and sow . Although corpora lutea of the sow have been shown to contain oxytocin it is the uterus of this species that produces the majority of oxytocin of reproductive tract origin [9, 10]. Similarly, in the rat  and apparently the mare  the uterus, and not the ovary, is the primary source of oxytocin.
Although oxytocin has been found to be synthesized by the corpus luteum of a number of mammalian species it is the presence of this nanopeptide in the corpora lutea of ruminants that has received considerable study. Focused interest on luteal oxytocin in these animals for the most part reflects research conducted to elucidate its role in processes of luteal regression. Therefore, the remaining aspects of this review on luteal oxytocin will encompass primarily research conducted on the ruminant.
To appreciate the unique facets of luteal oxytocin biosynthesis it is essential to recognize that initial expression of the oxytocin gene begins in the preovulatory follicle. Evidence for the existence of oxytocin in the preovulatory follicles of the cow and ewe was first reported by Wathes et al. [13, 14]. Subsequently, Voss and Fortune  measured in vitro oxytocin production by granulosa cells isolated from bovine preovulatory follicles during the early, mid- and late follicular phase. Granulosa cells isolated from the late stage preovulatory follicle, approximately 20 h after the onset of estrus, were found to produce maximal quantities of oxytocin as compared to granulosa cells recovered during the early and mid-follicular phase. These authors suggested that exposure of the granulosa cells to the surges of luteinizing hormone (LH) and follicle-stimulating hormone (FSH) may have either directly or indirectly stimulated synthesis of oxytocin. And indeed, when granulosa cells of preovulatory follicles were exposed to LH or FSH in vitro, a marked increase in oxytocin secretion occurred during the culture period [15, 16]. Similarly, incubation of granulosa cells isolated from an early preovulatory follicle with LH for 3 days induced transcription of the gene encoding oxytocin-neurophysin-I . Based upon the results of these studies, one might conclude that cells of the developing corpus luteum would respond to enhanced systemic concentrations of LH with an increase in oxytocin production. However, as described below, this does not occur.
It should be noted that there is an apparent asynchrony that characterizes the relationship between concentrations of oxytocin mRNA and the nanopeptide in luteal cells whereas the accumulation of mRNA and synthesis of oxytocin in granulosa cells is positively correlated. In the bovine and ovine corpus luteum it is the large luteal cells, believed to be derived from granulosa cells  that contain the secretory granules of oxytocin [19, 20]. In cows and ewes, the luteal concentration of oxytocin-neurophysin-I mRNA increases early after luteinization of granulosa cells to attain maximal levels by approximately day 3 of the estrous cycle, after which concentrations gradually decrease to low levels for the duration of the cycle [21, 22]. Presence of an embryo does not appear to alter the steady decline in luteal concentration of oxytocin mRNA that characteristically occurs in the cow during the estrous cycle . Luteal concentrations of oxytocin in cows and ewes are not highly correlated with the oxytocin mRNA, and actually do not reach maximal concentrations until near midcycle [24–26]. Thereafter, luteal oxytocin, like its mRNA, declines to lowest levels during proestrus of the ensuing cycle. The luteal tissue content of oxytocin is reduced markedly by the time of luteolysis . The lag period that characterizes the difference in luteal concentrations of oxytocin mRNA and the peptide during the estrous cycle may be attributed to the slow increase in activity of peptidyl glycine α-amidating mono-oxygenase, the terminal enzyme in the pathway of oxytocin synthesis . The increase in activity of this enzyme coincides with the gradual increase in luteal concentrations of oxytocin in the ewe, becoming maximal on day 8 of the estrous cycle. Ascorbic acid is a requisite cofactor of this enzyme but endogenous levels do not limit the activity of this enzyme. However, Luck and Jungclas  showed that ascorbate could stimulate oxytocin secretion by bovine luteinized granulosa cells in vitro.
Regulation of Oxytocin Gene Expression
One of the more perplexing aspects about luteal oxytocin pertains to identification of the transcription factors essential for gene expression. As described above, LH stimulates oxytocin gene transcription and mRNA translation in granulosa cells. Although small but not large bovine luteal cells are endowed with LH receptors it was anticipated that enhanced secretion of LH during the formative stages of luteal development might indirectly affect luteal concentrations of oxytocin. However, exposure of the developing bovine corpus luteum to periodic pulses of LH induced by administration of gonadotropin-releasing hormone (GnRH) from days 4 to 6 of the estrous cycle attenuated luteal concentrations of oxytocin (E.M. Jaeger, unpublished data). Thus, it does not appear that the large cells of the developing corpus luteum are affected by LH in the same manner as the granulosa cell before becoming luteinized. Voss and Fortune  reported that progesterone stimulated oxytocin secretion by bovine granulosa cells during the late stages of a 5 day culture. Ovine corpora lutea have been shown to possess nuclear progesterone receptors . Yet, administration of the progesterone antagonist mifepristone (RU 486) to ewes from days 2 through 5 of the cycle failed to affect luteal content of oxytocin . Although it is possible that the dose of RU 486 administered (175 mg/day) was insufficient, these data were interpreted to suggest that endogenous progesterone does not act in an autocrine/paracrine manner to affect oxytocin production by the developing corpus luteum of the ewe.
Multiple factors appear to be required to promote or suppress expression of the oxytocin gene. An imperfect palindromic sequence with similarity to estrogen response elements has been identified in the 5' flanking region of the human and rat oxytocin gene [33, 34]. The promoter region of the oxytocin gene in the cow also contains an imperfect response element for estrogen located proximal to the transcription start site . Using heterologous transfection systems the rat and human but not the bovine oxytocin gene can be stimulated by estradiol [33, 34]. Thus, response of the oxytocin gene to estrogen appears to be species specific. The promoter region of the human oxytocin gene contains four pentanucleotide repeats that bind retinoic acid . All four repeats are necessary for full retinoic acid responsiveness. The first two repeats most distal to the start site overlap the estrogen response element. In the absence of the two downstream repeats, binding of the retinoic acid receptor to the two upstream repeats results in a negative transcriptional effect and antagonizes the stimulatory effect of the estrogen receptor, most likely by competing for binding to the same site on the promoter. The promoter region of both the rat and human oxytocin gene contains response elements for thyroid hormone . In the case of the promoter region for the rat oxytocin gene, the two thyroid hormone response elements appear to overlap with the estrogen response element and reside further upstream of the estrogen response element. Based upon the available data, it appears that the upstream nucleotide sequence that encompasses the estrogen response element in the promoter region of the rat and human oxytocin gene may actually constitute a composite hormone response element to which different classes of nuclear hormone receptors bind.
According to Wehrenberg et al.  the promoter region of the bovine oxytocin gene has been shown to contain response elements for the two orphan receptors, steroidogenic factor-1 (SF-1) and chicken ovalbumin upstream promoter transcription factor (COUP-TF). Presence of SF-1 correlates well with maximal in vivo expression of the oxytocin gene in the developing bovine corpus luteum, i.e., with the increasing quantity of oxytocin mRNA being present immediately after ovulation. In contrast, the increased presence of COUP-TF in the bovine corpus luteum at midcycle, and thereafter, correlates with the down-regulation of the oxytocin gene. Interaction of SF-1 and (or) COUP-TF with other regulatory proteins, or specific modification of these orphan receptors, is probably needed for the up- and down-regulation that characterizes oxytocin gene expression in the corpus luteum.
In cultures of bovine granulosa cells recovered from preovulatory follicles and luteal cells of the developing corpus luteum the addition of insulin or insulin-like growth factor-1 (IGF-1) to the medium stimulated an increase in oxytocin production [39, 40]. The stimulatory effects of insulin and IGF-1 on oxytocin production by granulosa and luteal cells most likely reflect their transcriptional effects on expression of the oxytocin gene.
Overall, it is evident that a number of factors are capable of regulating oxytocin gene expression in various species. However, which specific factors interact to promote oxytocin gene expression in the corpus luteum remain elusive.
Induced Secretion of Luteal Oxytocin
Flint and Sheldrick  were the first to report that injection of ewes with prostaglandin F2α (PGF2α) analogue (cloprostenol) caused an immediate increase in luteal oxytocin secretion. Similarly, injection of PGF2α analogue into cows during the midluteal phase of the estrous cycle caused an immediate increase in luteal oxytocin secretion detectable in systemic blood within 5–15 min post-injection . Almost concurrently, McCracken and Schramm  advanced the hypothesis that episodic secretions of luteal oxytocin and uterine PGF2α are interrelated through a double positive feedback loop and thereby together promote regression of the corpus luteum. This proposed functional interrelationship between the ovary and uterus was supported by the observation of Flint and Sheldrick  and Walters et al.  who showed that onset of luteal regression in the ewe and cow is characterized by intermittent synchronous pulsatile secretion of oxytocin and PGF2α. Whether luteal oxytocin actually is necessary for promoting regression of the bovine corpus luteum is now controversial. In both the cow and ewe luteal concentrations of oxytocin at the end of a normal estrous cycle are less than during the midluteal phase of the cycle. Repeated infusions of norepinephrine into the abdominal aorta of heifers on days 15 and 16 of the estrous cycle caused diminished release of oxytocin in response to each succeeding infusion of the catecholamine . The authors estimated that repeated infusions of norepinephrine on days 15 and 16 depleted luteal oxytocin by 74%. Because this depletion of oxytocin had no effect on duration of the estrous cycle the authors concluded that luteal oxytocin had no direct action in luteolysis in cattle. However, it should be noted that administration of 500 μg of PGF2α analogue to heifers, with a corpus luteum presumably depleted of oxytocin, still caused a release of luteal oxytocin that attained a peak concentration of 50 pg/ml in systemic blood plasma. Some more recent conclusions that luteal oxytocin is nonessential in promoting onset of corpus luteum regression in the cow are based on the results of in vivo microdialysis experiments [47, 48]. Whether results of this type of invasive experimental approach in assessing luteal function can be considered to actually represent the function of the corpus luteum is questionable. Further, it may be premature to conclude by failure to measure oxytocin in systemic blood or microdialysates that this nanopeptide plays no role in luteal regression in the cow. Negative results obtained by microdialysis experiments may reflect the intraluteal placement of the microdialysis tubing.
Although norepinephrine has been shown to induce the secretion of bovine luteal oxytocin under experimental conditions it is unknown to what extent the endogenous neurotransmitter is involved in regulating the secretion of this nanopeptide. Norepinephrine apparently binds to a luteal β-adrenergic receptor to provoke release of oxytocin because response to the neurotransmitter is blocked by administration of propranolol but not phentolamine . On the other hand, much more is known about the mechanism of action of prostaglandin F2α. Receptors for PGF2α are found predominantly on the large luteal cells . Binding of PGF2α to its receptor activates phospholipase Cβ (PLC) via coupling with a Gq protein [51, 52]. Activation of PLC is the initial step of the phosphoinositide cascade that generates the second messengers diacylglycerol (DAG) and Ca2+ [53, 54]. Both DAG and Ca2+ are required for activation of the conventional class of protein kinase C isozymes (α, βI, βII, γ). In contrast, isozymes of the novel class of PKC (δ, ε, η, θ) lack the calcium binding domain found in the cPKCs, however, they are activated by phospholipids and DAG. Both these two classes of PKC isozymes can be activated by phorbol ester. The bovine corpus luteum contains predominantly PKCα and ε although isozymes βI and βII have been reported to be present [52, 55]. The increase in intracellular Ca2+ that occurs in response to PGF2α is believed to promote translocation of at least some PKC isozymes to the plasma membrane from a cytoplasmic site. Orwig et al.  demonstrated that PGF2α-induced luteal secretion of oxytocin was correlated with an increase in plasma membrane PKC activity. In order for exocytosis of oxytocin to occur, the vesicle bearing the oxytocin granule must pass through a cytoskeletal cortex consisting of cross-linked monomeric actin filaments that lie in close apposition to the plasma membrane . The actin filaments of the cortex are maintained in a particular geometrical configuration by actin binding proteins. A number of actin binding proteins have been identified but one in particular, a myristoylated alanine-rich C kinase substrate (MARCKS) protein, has been shown to be associated with PGF2α-induced secretion of oxytocin in the bovine corpus luteum . As the name implies this protein is phosphorylated by PKC and luteal concentrations of MARCKS mRNA and protein appear to correspond with those of oxytocin throughout the estrous cycle . In its unphosphorylated state, the protein is attached to the plasma membrane via the myristate moiety and its stability is maintained by electrostatic interaction with the membrane due to positively charged Lys/Arg residues found in its phosphorylation site domain . In vivo exposure of the bovine corpus luteum to PGF2α during the midluteal phase of the estrous cycle causes an immediate phosphorylation of MARCKS by activated PKC, with a resultant translocation of the phosphorylated MARCKS to the cytoplasm that is highly correlated with exocytosis of oxytocin .
Exposure of the mature corpus luteum to PGF2α has been shown to cause activation of MAPKinase-kinase-kinase (Raf-1) and downstream components of the MAPKinase pathway including the transcription factor C-Jun [61, 62]. The extent, if any, to which activation of this pathway is involved in the exocytosis of oxytocin is unknown.
Autocrine/Paracrine Action of Ovarian Oxytocin
Chandrasekher and Fortune  reported that oxytocin, in a dose-dependent manner, significantly increased progesterone production by cultured granulosa cells of bovine preovulatory follicles. Oxytocin was without effect on granulosa cell progesterone synthesis when cultures contained an oxytocin antagonist. Similarly, addition of graded doses of oxytocin to cultures of theca cells failed to affect steroidogenesis.
Although luteal oxytocin may indirectly promote luteolysis to establish the normal estrous cycle, at least in the ewe, the question remains as to the biological significance of the massive synthesis of the neuropeptide in the developing corpus luteum. Administration of various dosages of oxytocin to ewes for 3 to 4 day intervals throughout the estrous cycle failed to alter the duration of the cycle or affect luteal concentration of progesterone [64, 65]. These data might be interpreted to suggest that oxytocin has no direct effect on the corpus luteum. However, research by Tan et al. [66, 67] demonstrated that exposure of dispersed bovine and human luteal cells to low concentrations of oxytocin stimulated progesterone synthesis whereas higher concentrations of the nanopeptide were inhibitory. This research could not be confirmed by Richardson and Masson  using human luteal cells. On the other hand, using an in vitro microdialysis system Miyamoto and Schams  reported that oxytocin stimulated progesterone production by cells of the developing bovine corpus luteum (days 5 to 7 of the cycle) but was less effective on luteal cells collected later in the estrous cycle. Bovine luteal cells collected at various stages of the estrous cycle have been shown to possess oxytocin receptors . Surprisingly, addition of PGF2α but not PGE2 or estradiol to cultures of bovine luteal cells has been reported to cause upregulation of oxytocin receptors without changing the binding affinity .
In contrast to the stimulatory effect of oxytocin on bovine luteal cells, oxytocin in doses of 4 to 800 mU (1 mU = 2 ng) added to short term cultures of baboon luteal cells recovered during the early luteal phase of the cycle significantly suppressed progesterone production . When added to cultures of baboon luteal cells recovered during the midluteal phase of the cycle, oxytocin had no effect on progesterone production. In vitro progesterone production by cells of the baboon corpus luteum recovered during the late luteal phase of the cycle was suppressed by high doses of oxytocin only. In conclusion it appears that available data on the intraluteal effect of oxytocin on progesterone synthesis are quite equivocal. Further research is required to resolve the issue of whether or not oxytocin is essential for regulating steroidogenesis by the developing and mature corpus luteum.
While much knowledge exists about the biochemical and endocrine factors involved in regulating luteal oxytocin synthesis it is obvious that much has yet to be learned. Of particular interest is elucidation of the key factor(s) that are absent or present to limit transcription of the oxytocin gene during the cycle. Research is also needed to more precisely define the intraovarian or intraluteal action of oxytocin. It is presumed that future research will contribute vital new information about luteal oxytocin synthesis/secretion and action in the various mammalian species.
Ott I, Scott JC: The galactagogue action of the thymus and corpus luteum. Proc Soc Exp Biol. 1910, 8: 49-
Du Vigneaud V, Ressler C, Swan JM, Roberts CW, Katsoyannis PG, Gordon S: The synthesis of an octapeptide amide with the hormonal activity of oxytocin. J Am Chem Soc. 1953, 75: 4879-4880.
Wathes DC, Swann RW: Is oxytocin an ovarian hormone?. Nature. 1982, 297: 225-227.
Wathes DC, Swann RW, Birkett SD, Porter DG, Pickering BT: Characterization of oxytocin, vasopressin and neurophysin from the bovine corpus luteum. Endocrinology. 1983, 113: 693-698.
Khan-Dawood FS, Marut EL, Dawood MY: Oxytocin in the corpus luteum of Cynomolgus monkey (Macaca fascicularis). Endocrinology. 1984, 115: 570-574.
Homeida AM: Evidence for the presence of oxytocin in the corpus luteum of the goat. Br J Pharmacol. 1986, 87: 673-676.
Khan-Dawood FS, Huang J-C, Dawood MY: Baboon corpus luteum oxytocin: an intragonadal peptide modulator of luteal function. Am J Obstet Gynecol. 1988, 158: 882-891.
Jarry H, Einspanier A, Kanngieber L, Dietrich M, Pitzel L, Holtz W, Wuttke W: Release and effects of oxytocin on estradiol and progesterone secretion in porcine corpora lutea as measured by in vivo microdialysis system. Endocrinology. 1990, 126: 2350-2358.
Boulton MI, McGrath TJ, Goode JA, Broad KD, Gilbert CL: Changes in content of mRNA encoding oxytocin in the pig uterus during the oestrous cycle, pregnancy, at parturition and in lactational anoestrus. J Reprod Fertil. 1996, 108: 219-227.
Hu J, Ludwig TE, Salli U, Stormshak F, Mirando MA: Autocrine/paracrine action of oxytocin in pig endometrium. Biol Reprod. 2001, 64: 1682-1688.
Zingg HH, Rozen F, Chu K, Lareher A, Arslan A, Richard S, Lefebvre D: Oxytocin and oxytocin receptor gene expression in the uterus. Rec Prog Horm Res. 1995, 50: 255-273.
Behrendt-Adan CY, Adams MH, Simpson KS, McDowell KJ: Oxytocin-neurophysin I mRNA abundance in equine uterine endometrium. Dom Anim Endocrinol. 1999, 16: 183-192. 10.1016/S0739-7240(99)00008-9.
Wathes DC, Swann RW, Pickering BT: Variation in oxytocin, vasopressin and neurophysin concentrations in the bovine ovary during the oestrous cycle and pregnancy. J Reprod Fertil. 1984, 71: 551-557.
Wathes DC, Guldenaar SEF, Swann RW, Webb R, Porter DG, Pickering BT: A combined radioimmunoassay and immunocytochemical study of ovarian oxytocin production during the periovulatory period in the ewe. J Reprod Fertil. 1986, 78: 167-183.
Voss AK, Fortune JE: Oxytocin secretion by bovine granulosa cells: effects of stage of follicular development, gonadotropins, and coculture with theca interna. Endocrinology. 1991, 128: 1991-1999.
Schams D: Luteal peptides and intercellular communication. J Reprod Fertil Suppl. 1987, 34: 87-99.
Voss AK, Fortune JE: Oxytocin/neurophysin-I messenger ribonucleic acid in bovine granulosa cells increases after the luteinizing hormone (LH) surge and is stimulated by LH in vitro. Endocrinology. 1992, 131: 2755-2762. 10.1210/en.131.6.2755.
Alila HW, Hansel W: Origin of different cell types in the bovine corpus luteum as characterized by specific monoclonal antibodies. Biol Reprod. 1984, 31: 1015-1025.
Fields MJ, Fields PA: Luteal neurophysin in the nonpregnant cow and ewe: immunocytochemical localization in membrane-bound secretory granules of the large luteal cell. Endocrinology. 1986, 118: 1723-1725.
Theodosis DT, Wooding FBP, Sheldrick EL, Flint APF: Ultrastructural localization of oxytocin and neurophysin in the ovine corpus luteum. Cell Tissue Res. 1986, 243: 129-145.
Ivell R, Brackett K, Fields MJ, Richter D: Ovulation triggers oxytocin gene expression in the bovine ovary. FEBS Lett. 1985, 190: 263-267. 10.1016/0014-5793(85)81296-5.
Jones DSC, Flint APF: Concentrations of oxytocin-neurophysin prohormone mRNA in corpora lutea of sheep during the oestrous cycle and in early pregnancy. J Endocrinol. 1988, 117: 409-414.
Nichols NE, Binta HP, Fields PA, Drost M, Campbell-Thompson M, Ivell R, Chang S-M, Johnson E, Fields MJ: Expression and localization of oxytocin and relaxin-like factor during the peri-implantation period of bovine pregnancy. Biol Reprod Suppl. 2003, 1: 335-
Sheldrick EL, Flint APF: Luteal concentrations of oxytocin decline during early pregnancy in the ewe. J Reprod Fertil. 1983, 68: 477-480.
Abdelgadir SE, Swanson LV, Oldfield JE, Stormshak F: Prostaglandin F2α-induced release of oxytocin from bovine corpora lutea in vitro. Biol Reprod. 1987, 37: 550-555.
Parkinson TJ, Wathes DC, Jenner IJ, Lamming GE: Plasma and luteal concentrations of oxytocin in cyclic and early pregnant cattle. J Reprod Fertil. 1992, 94: 161-167.
Wathes DC, Swann RW, Pickering BT: Variation in oxytocin, vasopressin and neurophysin concentrations in the bovine ovary during the oestrous cycle and pregnancy. J Reprod Fertil. 1984, 71: 551-557.
Sheldrick EL, Flint APF: Post-translational processing of oxytocin-neurophysin prohormone in the ovine corpus luteum: activity of peptidylglycine α-amidating mono-oxygenase and concentrations of its cofactor, ascorbic acid. J Endocrinol. 1989, 122: 313-322.
Luck MR, Jungclas B: Catecholamines and ascorbic acid as stimulators of bovine ovarian oxytocin secretion. J Endocrinol. 1987, 114: 423-430.
Voss AK, Fortune JE: Estradiol-17β has a biphasic effect on oxytocin secretion by bovine granulosa cells. Biol Reprod. 1993, 48: 1404-1409.
Smith GW, Gentry PC, Long DK, Bao B, Roberts RM, Smith MF: Expression of progesterone receptor mRNA within ovine post-surge follicles and corpora lutea. Biol Reprod Suppl. 1995, 1: 151-
Paslay EM, Jaeger JR, Salli U, Stormshak F: Ovarian function in ewes after treatment with mifepristone early during the oestrous cycle. Reproduction. 2003, 125: 205-210. 10.1530/reprod/125.2.205.
Richard S, Zingg HH: The human oxytocin gene promoter is regulated by estrogens. J Biol Chem. 1990, 265: 6098-6103.
Adan RAH, Walther N, Cox JJ, Ivell R, Burbach JPH: Comparison of the estrogen responsiveness of the rat and bovine oxytocin gene promoters. Biochem Biophys Res Comm. 1991, 175: 117-122.
Walther N, Wehrenberg U, Brackmann B, Ivell R: Mapping of the bovine oxytocin gene control region: identification of binding sites for luteal nuclear proteins in the 5' non-coding region of the gene. J Neurosci. 1991, 3: 540-549.
Richard S, Zingg HH: Identification of a retinoic acid response element in the human oxytocin promoter. J Biol Chem. 1991, 266: 21428-21433.
Adan RAH, Cox JJ, vanKats JP, Burbach JPH: Thyroid hormone regulates the oxytocin gene. J Biol Chem. 1992, 267: 3771-3777.
Wehrenberg U, Ivell R, Jansen M, von Goedecke S, Walther N: Two orphan receptors binding to a common site are involved in the regulation of the oxytocin gene in the bovine ovary. Proc Natl Acad Sci USA. 1994, 91: 1440-1444.
McArdle CA, Holtorf A-P: Oxytocin and progesterone release from bovine corpus luteal cells in culture: effects of insulin-like growth factor-1, insulin, and prostaglandins. Endocrinology. 1989, 124: 1278-1286.
Holtorf A-P, Furuya K, Ivell R, McArdle CA: Oxytocin production and oxytocin messenger ribonucleic acid levels in bovine granulosa cells are regulated by insulin and insulin-like growth factor-1: dependence on developmental status of the ovarian follicle. Endocrinology. 1989, 125: 2612-2620.
Flint APF, Sheldrick EL: Ovarian secretion of oxytocin is stimulated by prostaglandin. Nature. 1982, 297: 587-588.
Schallenberger E, Schams D, Bullermann B, Walters DL: Pulsatile secretion of gonadotrophins, ovarian steroids and ovarian oxytocin during prostaglandin-induced regression of the corpus luteum in the cow. J Reprod Fertil. 1984, 71: 493-501.
McCracken JA, Schramm W: Prostaglandins and corpus luteum regression. In: A Handbook of Prostaglandins and Related Compounds. Edited by: PB Curtis-Prior. 1983, Churchill-Livingstone, Edinburgh, 1-104.
Flint APF, Sheldrick EL: Evidence for a systemic role for ovarian oxytocin in luteal regression in sheep. J Reprod Fertil. 1983, 67: 215-222.
Walters DL, Schams D, Schallenberger E: Pulsatile secretion of gonadotrophins, ovarian steroids, and ovarian oxytocin during the luteal phase of the oestrous cycle in the cow. J Reprod Fertil. 1984, 71: 479-491.
Kotwica J, Skarzynski D: Influence of oxytocin removal from the corpus luteum on secretory function and duration of the oestrous cycle in cattle. J Reprod Fertil. 1993, 97: 411-417.
Blair RM, Saatman R, Lion SS, Fortune JE, Hansel W: Roles of leukotrienes in bovine corpus luteum regression: an in vivo microdialysis study. Proc Soc Exp Biol Med. 1997, 216: 72-80.
Shaw DW, Britt JH: In vivo oxytocin release from microdialyzed bovine corpora lutea during spontaneous and prostaglandin-induced regression. Biol Reprod. 2000, 62: 726-730.
Skarzynski D, Kotwica J: Mechanism of noradrenaline influence on the secretion of ovarian oxytocin and progesterone in conscious cattle. J Reprod Fertil. 1993, 97: 419-424.
Fitz TA, Mayan MH, Sawyer HR, Niswender GD: Characterization of two steroidogenic cell types in the ovine corpus luteum. Biol Reprod. 1982, 27: 703-711.
Smrcka AV, Hepler JR, Brown KO, Sternweis PC: Regulation of polyphosphoinositide-specific phospholipase C activity by purified Gq. Science. 1991, 251: 804-807.
Davis JS, May JV, Keel BA: Mechanisms of hormone and growth factor action in the bovine corpus luteum. Theriogenology. 1996, 45: 1351-1380. 10.1016/0093-691X(96)00101-X.
Leung PC, Minegishi T, Ma F, Zhou R, Ho-Yuen B: Induction of polyphosphoinositide breakdown in rat corpus luteum by prostaglandin F2α. Endocrinology. 1986, 119: 12-18.
Davis JS, Alila HW, West LA, Corradino RA, Hansel W: Acute effects of prostaglandin F2α on inositol phospholipid hydrolysis in the large and small cells of the bovine corpus luteum. Mol Cell Endocrinol. 1988, 58: 43-50. 10.1016/0303-7207(88)90052-4.
Orwig KE, Bertrand JE, Ou B-R, Forsberg NE, Stormshak F: Immunochemical characterization and cellular distribution of protein kinase C isozymes in the bovine corpus luteum. Comp Biochem Physiol. 1994, 108B: 53-57.
Orwig KE, Bertrand JE, Ou B-R, Forsberg NE, Stormshak F: Involvement of protein kinase-C, calpains, and calpastin in prostaglandin F2α-induced oxytocin secretion from the bovine corpus luteum. Endocrinology. 1994, 134: 78-83. 10.1210/en.134.1.78.
Alberts B, Bray D, Lewis J, Raff M, Roberts K, Watson JD: Molecular Biology of the Cell. 1994, Garland Publishing Inc., New York, 793-847. 3
Salli U, Supancic S, Stormshak F: Phosphorylation of myristoylated alanine-rich C kinase substrate (MARCKS) protein is associated with bovine luteal oxytocin exocytosis. Biol Reprod. 2000, 63: 12-20.
Filley S, Supancic S, Salli U, Orwig K, Stormshak F: Myristoylated alanine-rich C kinase substrate protein and mRNA in bovine corpus luteum during the estrous cycle. Endocrine. 2000, 12: 289-294. 10.1385/ENDO:12:3:289.
McLaughlin S, Aderem A: The myristoylated-electrostatic switch: a modulator of reversible protein-membrane interactions. Trends Biochem Sci. 1995, 20: 272-276. 10.1016/S0968-0004(00)89042-8.
Chen D-B, Westfall SD, Fong HW, Roberson MS, Davis JS: Prostaglandin F2α stimulates the Raf/MEK1/mitogen-activated protein kinase signaling cascade in bovine luteal cells. Endocrinology. 1998, 139: 3876-3885. 10.1210/en.139.9.3876.
Bertrand JE, Stormshak F: In vivo and in vitro responses of the bovine corpus luteum after exposure to exogenous gonadotropin-releasing hormone and prostaglandin F2α. Endocrine. 1996, 4: 165-173.
Chandrasekher YA, Fortune JE: Effects of oxytocin on steroidogenesis by bovine theca and granulosa cells. Endocrinology. 1990, 127: 926-933.
Milne JA: Effects of oxytocin on the oestrous cycle of the ewe. Aust Vet J. 1963, 39: 51-52.
Milvae RA, Duby RT, Tritschler JP, Pekala RF, Gnatek GG, Bushmich SL, Schreiber DT: Function and lifespan of corpora lutea in ewes treated with exogenous oxytocin. J Reprod Fertil. 1991, 92: 133-138.
Tan GJS, Tweedale R, Biggs JSG: Effects of oxytocin on the bovine corpus luteum of early pregnancy. J Reprod Fertil. 1982, 66: 75-78.
Tan GJS, Tweedale R, Biggs JSG: Oxytocin may play a role in the control of the human corpus luteum. J Endocrinol. 1982, 95: 65-70.
Richardson MC, Masson GM: Lack of direct inhibitory action of oxytocin on progesterone production by dispersed cells from human corpus luteum. J Endocrinol. 1985, 104: 149-151.
Miyamoto A, Schams D: Oxytocin stimulates progesterone release from microdialyzed bovine corpus luteum in vitro. Biol Reprod. 1991, 44: 1163-1170.
Okuda K, Miyamoto A, Sauerwein H, Schweigert FJ, Schams D: Evidence for oxytocin receptors in cultured bovine luteal cells. Biol Reprod. 1992, 46: 1001-1006.
Okuda K, Uenoyama Y, Miyamoto A, Okano A, Schweigert FJ, Schams D: Effects of prostaglandins and oestradiol-17β on oxytocin binding in cultured bovine luteal cells. Reprod Fertil Dev. 1995, 7: 1045-1051.
About this article
Cite this article
Stormshak, F. Biochemical and endocrine aspects of oxytocin production by the mammalian corpus luteum. Reprod Biol Endocrinol 1, 92 (2003). https://doi.org/10.1186/1477-7827-1-92